IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 155 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $333,000 | -74.6% | 20,000 | -70.9% | 0.22% | -72.6% |
| Q4 2021 | $1,313,000 | -80.6% | 68,800 | -75.0% | 0.79% | -78.9% |
| Q3 2021 | $6,776,000 | +87.5% | 274,761 | +97.8% | 3.73% | +65.0% |
| Q2 2021 | $3,614,000 | -9.0% | 138,886 | +15.2% | 2.26% | +19.7% |
| Q3 2020 | $3,970,000 | -32.7% | 120,606 | -43.9% | 1.89% | -25.5% |
| Q2 2020 | $5,902,000 | -64.4% | 215,000 | -61.1% | 2.53% | -67.3% |
| Q1 2020 | $16,557,000 | +53.9% | 553,100 | +42.3% | 7.74% | +63.9% |
| Q4 2019 | $10,756,000 | +70.7% | 388,600 | +12.3% | 4.72% | +35.1% |
| Q3 2019 | $6,300,000 | -35.8% | 346,149 | -13.5% | 3.50% | -29.3% |
| Q2 2019 | $9,808,000 | +12.5% | 400,000 | -56.4% | 4.94% | +29.6% |
| Q1 2019 | $8,721,000 | -7.3% | 917,080 | -13.7% | 3.82% | -21.4% |
| Q4 2018 | $9,403,000 | +16.9% | 1,062,500 | +48.5% | 4.85% | +8.2% |
| Q3 2018 | $8,047,000 | +42.9% | 715,317 | +62.6% | 4.49% | +8.7% |
| Q2 2018 | $5,631,000 | +58.8% | 439,900 | +109.6% | 4.13% | +85.6% |
| Q1 2018 | $3,546,000 | -12.6% | 209,842 | -58.6% | 2.22% | -25.4% |
| Q4 2017 | $4,055,000 | – | 506,852 | – | 2.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |